These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 28450225)

  • 21. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ST2/IL-33 signaling in cardiac fibrosis.
    Vianello E; Dozio E; Tacchini L; Frati L; Corsi Romanelli MM
    Int J Biochem Cell Biol; 2019 Nov; 116():105619. PubMed ID: 31561019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers.
    Sánchez-Más J; Lax A; Asensio-López Mdel C; Fernandez-Del Palacio MJ; Caballero L; Santarelli G; Januzzi JL; Pascual-Figal DA
    Eur J Clin Invest; 2014 Jul; 44(7):643-51. PubMed ID: 24837094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction.
    Lax A; Sanchez-Mas J; Asensio-Lopez MC; Fernandez-Del Palacio MJ; Caballero L; Garrido IP; Pastor-Perez FJ; Januzzi JL; Pascual-Figal DA
    JACC Heart Fail; 2015 Jan; 3(1):50-58. PubMed ID: 25458175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
    Pusceddu I; Dieplinger B; Mueller T
    Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure.
    Byrne NJ; Soni S; Takahara S; Ferdaoussi M; Al Batran R; Darwesh AM; Levasseur JL; Beker D; Vos DY; Schmidt MA; Alam AS; Maayah ZH; Schertzer JD; Seubert JM; Ussher JR; Dyck JRB
    Circ Heart Fail; 2020 Jun; 13(6):e006573. PubMed ID: 32493060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of IL-33/ST2 pathway in acute inflammation on tissue damage, antioxidative parameters, magnesium concentration and cytokines profile.
    Stankovic MS; Janjetovic K; Velimirovic M; Milenkovic M; Stojkovic T; Puskas N; Zaletel I; De Luka SR; Jankovic S; Stefanovic S; Japundzic-Zigon N; Petronijevic ND; Trajkovic V; Trbovich AM
    Exp Mol Pathol; 2016 Aug; 101(1):31-7. PubMed ID: 27222019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress.
    Kazakov A; Hall RA; Werner C; Meier T; Trouvain A; Rodionycheva S; Nickel A; Lammert F; Maack C; Böhm M; Laufs U
    Basic Res Cardiol; 2018 Sep; 113(6):42. PubMed ID: 30191336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ST2 silencing aggravates ventricular remodeling and chronic heart failure in rats by mediating the IL-33/ST2 axis.
    Zhao YN; Li H; Zhao C; Liu GH
    J Tissue Eng Regen Med; 2020 Sep; 14(9):1201-1212. PubMed ID: 32592632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The GABA
    Bu J; Huang S; Wang J; Xia T; Liu H; You Y; Wang Z; Liu K
    Front Immunol; 2021; 12():670153. PubMed ID: 34135897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice.
    Velten M; Duerr GD; Pessies T; Schild J; Lohner R; Mersmann J; Dewald O; Zacharowski K; Klaschik S; Hilbert T; Hoeft A; Baumgarten G; Meyer R; Boehm O; Knuefermann P
    Cardiovasc Res; 2012 Dec; 96(3):422-32. PubMed ID: 22977006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
    Bansal SS; Ismahil MA; Goel M; Zhou G; Rokosh G; Hamid T; Prabhu SD
    Circulation; 2019 Jan; 139(2):206-221. PubMed ID: 30586716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eplerenone-mediated regression of electrical activation delays and myocardial fibrosis in heart failure.
    J Cardiovasc Electrophysiol; 2014 May; 25(5):556-577. PubMed ID: 24612029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
    Mulvihill EE; Varin EM; Ussher JR; Campbell JE; Bang KW; Abdullah T; Baggio LL; Drucker DJ
    Diabetes; 2016 Mar; 65(3):742-54. PubMed ID: 26672095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction.
    Bae S; Singh SS; Yu H; Lee JY; Cho BR; Kang PM
    J Appl Physiol (1985); 2013 Apr; 114(8):979-87. PubMed ID: 23429874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.
    Higashikuni Y; Sainz J; Nakamura K; Takaoka M; Enomoto S; Iwata H; Tanaka K; Sahara M; Hirata Y; Nagai R; Sata M
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):654-61. PubMed ID: 22116099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced activin receptor-like kinase 1 activity promotes cardiac fibrosis in heart failure.
    Morine KJ; Qiao X; Paruchuri V; Aronovitz MJ; Mackey EE; Buiten L; Levine J; Ughreja K; Nepali P; Blanton RM; Oh SP; Karas RH; Kapur NK
    Cardiovasc Pathol; 2017; 31():26-33. PubMed ID: 28820968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy.
    Higuchi Y; McTiernan CF; Frye CB; McGowan BS; Chan TO; Feldman AM
    Circulation; 2004 Apr; 109(15):1892-7. PubMed ID: 15051641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.